Bottle Label (Clarus 158mg)
Jatenzo Capsule, Liquid Filled
Product Images NDC 69087-237
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jatenzo (NDC 69087-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tolmar Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bottle Label (Clarus 198mg)
Jatenzo is a medication containing testosterone undecanoate and is prescribed for oral use. It is stored at a temperature between 20°C-25°C and contains FDC Yellow #6. It is important to keep this medicine out of reach of children. For complete prescribing information, see the package insert. The medication is available in 120 soft gel capsules with the name Jatenzo and the prescription label Rx 1205t Gt capsules CIATUS. However, the text has some errors and inconsistencies making it harder to say anything further.*
Bottle Label (Clarus 237mg)
JATENZO is a medication that is taken orally and contains Testosterone Undecanoate. It comes in the form of soft gelatin capsules. It is important to store the medication at temperatures between 20°C-25°C (68°F-77°F), but it is acceptable for the medication to be kept at temperatures ranging from 5°C-30°C (55°F-86°F) for a short period of time. It is essential to keep this medication out of the reach of children. It is worth noting that the capsules contain FOBC Yellow #6. Additional prescribing information is available in the package insert. Nocesosr2zriz 57225k and the NDC number 69087-257:12 are also provided. However, it should only be taken upon prescription (RX only clarus).*
Figure 1 (Jat01 0002 01)
Figure 2 (Jat01 0002 02)
This is a table showing the plasma T concentration in ng/dL at various time intervals after taking a dose of JATENZO. The time intervals are given in hours, starting from hour 2 and ending at hour 12. The specific data points for T concentration are not provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
